Devil's Deal?

While personalized medicine may be able to tailor treatments to patients' specific maladies, Eleonore Pauwels and Jim Dratwa from the Woodrow Wilson International Center wonder whether it is a sort of Faustian bargain. Many of the people who contribute their DNA toward the development of personalized medicine may not be able to reap its benefits, they write at the Scientific American Guest Blog.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.